Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

CEVA101: Ph I data

February 10, 2017 8:42 PM UTC

Data from the Phase I portion of an open-label, dose-escalation, U.S. Phase I/II trial in 25 adults with severe TBI and without signs of irreversible brain injury showed that 6, 9 and 12×106 cells/kg ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Fortress Biotech Inc.